- Home
- RELL vs MIST Comparison
RELL vs MIST Comparison
Compare RELL & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELL | MIST |
|---|---|---|
| Founded | 1947 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.6M | 176.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RELL | MIST |
|---|---|---|
| Price | $10.85 | $1.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 80.1K | ★ 3.4M |
| Earning Date | 01-07-2026 | 03-12-2026 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | ★ 71.90 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $212,588,000.00 | N/A |
| Revenue This Year | $5.91 | N/A |
| Revenue Next Year | $13.64 | N/A |
| P/E Ratio | $195.14 | ★ N/A |
| Revenue Growth | ★ 4.74 | N/A |
| 52 Week Low | $7.57 | $0.63 |
| 52 Week High | $13.88 | $3.06 |
Technical Indicators
Market Signals| Indicator | RELL | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 50.71 | 41.12 |
| Support Level | $10.43 | $1.97 |
| Resistance Level | $11.06 | $2.06 |
| Average True Range (ATR) | 0.43 | 0.12 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 54.85 | 18.75 |
Price Performance
Historical ComparisonAbout RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).